NAICS Code 325412-14 - Nuclear Medicine Supplies & Acces (Manufacturing)

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 50
Contact Emails: 80
Company Websites: 50
Phone Numbers: 50
Business Addresses: 50
Companies with Email: 27
Get Business List
NAICS CODE 325412-14
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research ‐ Free Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 325412 - Pharmaceutical Preparation Manufacturing - 1,726 companies, 213,574 emails.

NAICS Code 325412-14 Description (8-Digit)

Nuclear Medicine Supplies & Acces (Manufacturing) is a subdivision of the Pharmaceutical Preparation Manufacturing industry that involves the production of radioactive pharmaceuticals used in diagnostic and therapeutic procedures. This industry is responsible for manufacturing radiopharmaceuticals, which are drugs that contain radioactive isotopes and are used in nuclear medicine imaging and therapy. The production of these radiopharmaceuticals requires strict adherence to safety protocols and regulations to ensure the safety of both the workers and the patients who will be receiving the drugs.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 325412 page

Tools

Tools commonly used in the Nuclear Medicine Supplies & Acces (Manufacturing) industry for day-to-day tasks and operations.

  • Cyclotron
  • Radioisotope generator
  • Hot cell
  • Dose calibrator
  • Gamma counter
  • Liquid scintillation counter
  • High-performance liquid chromatography (HPLC)
  • Gas chromatography (GC)
  • Mass spectrometer
  • Radioactivity detector

Industry Examples of Nuclear Medicine Supplies & Acces (Manufacturing)

Common products and services typical of NAICS Code 325412-14, illustrating the main business activities and contributions to the market.

  • Radiopharmaceuticals
  • Technetium-99m generators
  • Iodine-131 capsules
  • Fluorodeoxyglucose (FDG)
  • Strontium-89 chloride
  • Samarium-153 lexidronam
  • Lutetium-177 dotatate
  • Yttrium-90 ibritumomab tiuxetan
  • Radium-223 dichloride
  • Gallium-68 dotatate

History

A concise historical narrative of NAICS Code 325412-14 covering global milestones and recent developments within the United States.

  • The Nuclear Medicine Supplies & Access (Manufacturing) industry has a relatively short history, dating back to the 1950s when the first nuclear medicine procedures were developed. The industry has since grown to become an essential part of modern medicine, with the development of new technologies and advancements in radiopharmaceuticals. Notable milestones include the development of the first gamma camera in the 1960s, the introduction of positron emission tomography (PET) in the 1970s, and the development of single-photon emission computed tomography (SPECT) in the 1980s. In recent years, the industry has seen significant growth due to the increasing demand for nuclear medicine procedures and the development of new radiopharmaceuticals. In the United States, the Nuclear Medicine Supplies & Access (Manufacturing) industry has experienced steady growth over the past few decades. The industry has benefited from advancements in technology, such as the development of new radiopharmaceuticals and imaging equipment, as well as an aging population that requires more medical procedures. The industry has also faced challenges, such as regulatory changes and the rising cost of healthcare. Despite these challenges, the industry is expected to continue to grow in the coming years, driven by the increasing demand for nuclear medicine procedures and the development of new technologies.